Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
–News Direct– ORLANDO, FL / September 20, 2023 (PlatoData via 500NewsWire) — Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with…